Non-alcoholic fatty liver disease (NAFLD) occurs when excess fat ... drug sensitivity and treatment paradigms for the affected population. Here, Dewald et al. generated liver-specific DM1 mice ...
Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...
SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the ...